Skip To Content

Study ID: Incyte Cholangiocarcinoma INCB 54828-202

Title:

A Phase 2, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma With FGFR2 Translocations, Other FGF/FGFR Alterations or Negative FGF/FGFR Alterations Who Failed Previous Therapy

Location:
Sioux Falls Region
Principal Investigator:
Jonathan Bleeker, MD
Disease:
Gastrointestinal, Other
Stage:
Phase II
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.